INDU Committee Meeting
Notices of Meeting include information about the subject matter to be examined by the committee and date, time and place of the meeting, as well as a list of any witnesses scheduled to appear. The Evidence is the edited and revised transcript of what is said before a committee. The Minutes of Proceedings are the official record of the business conducted by the committee at a sitting.
For an advanced search, use Publication Search tool.
If you have any questions or comments regarding the accessibility of this publication, please contact us at accessible@parl.gc.ca.
Notice of meeting Amended
Standing Committee on Industry and Technology (INDU)
44th Parliament, 1st Session
Meeting 17
Friday, April 8, 2022, 1:00 p.m. to 3:00 p.m.
Webcast
WitnessesAmended
1:00 p.m. to 2:00 p.m.
Department of Industry
Eric Costen, Senior Assistant Deputy Minister, Industry Sector
Rodrigo Arancibia, Senior Director, Life Sciences and Biomanufacturing Branch
Darryl C. Patterson, Director General, Life Sciences and Biomanufacturing Branch
Daniel Quinn, Director, Research Infrastructure and Outreach, Science and Research Sector
National Research Council of Canada
Maria Aubrey, Vice-President, Strategic Initiatives
Lakshmi Krishnan, Vice-President, Life Sciences
2:00 p.m. to 3:00 p.m.
As an individual
Dr. Alain Lamarre, Full Professor, Institut national de la recherche scientifique
BioNiagara
John R. Fulton, President, Spokesperson and Representative for Biolyse Pharma Corporation
Amended Section
BIOTECanada
Andrew Casey, President and Chief Executive Officer
BioVectra Inc.
Oliver Technow, Chief Executive Officer
Dr. Marc Sauer, Vice-President, Process Science and Development Services
Vaccine and Infectious Disease Organization - International Vaccine Centre
Dr. Volker Gerdts, Director and Chief Executive Officer
Clerk of the committee
Michael MacPherson (613-947-1971)
2022-04-06 12:02 p.m.